Healthcare stocks advanced broadly on Wall Street so far on Monday, with the sector seeing an overall increase of 0.5%. More broadly, the Dow Jones Industrial Average pushed 0.1% higher, the Nasdaq was unchanged and the S&P 500 climbed 0.1%.
Investor Place · 4/29/2014
Furiex Pharmaceuticals, Inc. (FURX) was a big mover last session, as the company saw its shares rise by nearly 130% on the day. The move came on solid volume too with far more shares changing hands than in a normal session after the company …
Yahoo Finance · 2/5/2014
NEW YORK (TheStreet) -- Furiex Pharmaceuticals (FURX) surged 28.57% to $103.05 at the close of trading on Monday after Forest Laboratories (FRX) announced it would acquire the company for $1.5 billion. This deal comes more than two months after …
The Street · 2/4/2004
More from Bing News
Furiex Pharmaceuticals, Inc. ( FURX) was a big mover last session ... for patients suffering from diarrhea-predominant irritable bowel syndrome. The stock picked up sharply from the near-flat trend of $41.72 to $47.40 in the past one-month time frame.
NASDAQ · 2/5/2014
Furiex Pharmaceuticals Inc (NASDAQ:FURX) stock jumped up by a huge 118 percent during premarket trading today on the back of its announcement of positive updates from its Phase 3 clinical trial for its target drug “eluxadoline”. The Morrisville ...
Live Trading News · 2/4/2014
Peter Kolchinsky‘s Ra Capital Management, has just disclosed initiating a 7.2% stake in Furiex Pharmaceuticals Inc (NASDAQ:FURX). The position amasses 750,000 shares and is passive by nature. The value of the holding amounts to $84.23 million, at …
Combining these strategies recently provided a 'home run' for my portfolio with Furiex Pharmaceuticals (NASDAQ:FURX). The stock is up more than 400% since I spotted it in July 2012 due to significant insider buying back then. Recently 24/7 WallStreet ...
Seeking Alpha · ByBret Jensen · 2/10/2014
On Tuesday, small cap Furiex Pharmaceuticals surged 129.91% to $105.69 (FURX has a 52 week trading range of $32.01 to $121.97 a share) for a market cap of $1.10 billion plus the stock is up 208.9% over the past year and up 724.4% since June 2010.
Smallcap Network · ByJohn Udovich · 2/5/2014
The benchmark index keeps hitting records, as stocks are being supported ... Forest Laboratories announced a deal to acquire Furiex Pharmaceuticals Inc. US:FURX for $1.1 billion in cash, which comes to roughly $95 a share, or a 19% premium.
Market Watch · 6/2/2014
FURX operates in the Drugs & Pharmaceuticals sector, among companies like McKesson Corp. (NYSE: MCK) which is up about 1.6% today, and Allergan, Inc (NYSE: AGN) trading up by about 2.3%. Below is a three month price history chart comparing …
Forbes · 12/9/2011